Detalhe da pesquisa
1.
Efficacy of preexposure prophylaxis with monoclonal-antibody tixagevimab-cilgavimab against emerging SARS-CoV-2 resistant variants in patients with chronic lymphocytic leukemia.
Acta Haematol
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38471491
2.
Ep300 sequestration to functionally distinct glucocorticoid receptor binding loci underlie rapid gene activation and repression.
Nucleic Acids Res
; 50(12): 6702-6714, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713523
3.
Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019-2020 A(H1N1)pdm09 predominant influenza season in Israel.
J Med Virol
; 95(2): e28498, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653733
4.
BNT162b2-vaccine-induced neutralization responses are immune correlates of clinical protection against SARS-CoV-2 in heart transplant recipients.
Clin Transplant
; 37(11): e15091, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572313
5.
Early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience.
J Infect Dis
; 225(5): 785-792, 2022 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850049
6.
Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022.
Euro Surveill
; 27(44)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36330820
7.
The impact of SARS-CoV-2 on respiratory syndromic and sentinel surveillance in Israel, 2020: a new perspective on established systems.
Euro Surveill
; 27(16)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35451365
8.
COVID-19 vaccination and BA.1 breakthrough infection induce neutralising antibodies which are less efficient against BA.4 and BA.5 Omicron variants, Israel, March to June 2022.
Euro Surveill
; 27(30)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904058
9.
Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
J Infect Dis
; 224(4): 616-619, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398244
10.
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel.
Euro Surveill
; 26(26)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34212838
11.
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021.
Euro Surveill
; 26(45)2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34763751
12.
Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection.
N Engl J Med
; 386(5): 492-494, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965337
13.
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
N Engl J Med
; 386(14): 1377-1380, 2022 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297591
14.
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2.
N Engl J Med
; 384(25): 2453-2454, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826815
15.
Neutralization of SARS-CoV-2 variants elicited by the combination of vaccination and natural infection in heart transplant recipients.
Clin Transplant
; 37(11): e15092, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565618
16.
Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients.
J Heart Lung Transplant
; 43(7): 1188-1192, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38522765
17.
Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients.
J Heart Lung Transplant
; 42(8): 1054-1058, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084801
18.
Immunogenicity of Co-Administered Omicron BA.4/BA.5 Bivalent COVID-19 and Quadrivalent Seasonal Influenza Vaccines in Israel during the 2022-2023 Winter Season.
Vaccines (Basel)
; 11(10)2023 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897026
19.
Influenza vaccine compatibility among hospitalized patients during and after the COVID-19 pandemic.
Front Microbiol
; 14: 1296179, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38322758
20.
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up.
Clin Microbiol Infect
; 29(7): 918-923, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921715